DailyMed label
Rivastigmine Tartrate
DailyMed label · Cadila Pharmaceuticals Limited · version 6
Key facts
| Product | Rivastigmine Tartrate |
|---|---|
| Labeler | Cadila Pharmaceuticals Limited |
| Document type | Human Prescription Drug Label |
| Active ingredients | RIVASTIGMINE TARTRATE |
| Active ingredient UNIIs | 9IY2357JPE |
| Application number | 203844 |
| Route | ORAL |
| NDC package codes | 71209-012-03, 71209-012-10, 71209-013-03, 71209-013-10, 71209-014-03, 71209-014-10, 71209-015-03, 71209-015-10 |
| Effective date | Dec 29, 2022 |
| Set ID | e7e641fe-39bd-4681-a430-6dedeb6d6af5 |
At a glance
- 1–9 NDC package codes
- 1–9 Active ingredients
- 1–9 Manufacturing establishments listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About DailyMed drug labels
DailyMed publishes the structured product labeling (SPL) that companies submit to the FDA, including package NDCs, ingredients and the establishments that make each product.
Source: U.S. National Library of Medicine (NLM), DailyMed · Source date: